Man Group plc

Position in KURA — Kura Oncology, Inc.

CIK 1637460 LONDON, X0

Position in KURA

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$3,861,969

+$1,352,379 QoQ

Shares Held

475,027

+96.7% QoQ

Ownership

0.535%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2020

10 quarters on record

Voting authority Sole 73.93327116142872.ToString("F0")% Shared 0.ToString("F0")% None 26.06672883857128.ToString("F0")%

Healthcare · as of Mar 31, 2026

Man Group plc holds $1,080,100,046 across 125 Biotechnology names. KURA ranks #35 (0.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	REGN	Regeneron Pharmaceuticals, Inc.	315,212	$243,545,399
2	VRTX	Vertex Pharmaceuticals Inc / Ma	236,798	$105,739,778
3	INCY	Incyte Corp	930,171	$87,547,693
4	ALNY	Alnylam Pharmaceuticals, Inc.	232,369	$76,883,931
5	ONC	BeOne Medicines Ltd.	241,922	$71,843,576
6	APLS	Apellis Pharmaceuticals, Inc.	915,689	$36,838,167
7	RVMD	Revolution Medicines, Inc.	275,270	$26,770,006
8	JAZZ	Jazz Pharmaceuticals plc	135,212	$25,561,828

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$3,861,969	475,027	+96.7%	Shares	Defined	2026-05-15
2025-12-31	$2,509,590	241,539	-47.3%	Shares	Defined	2026-02-17
2025-09-30	$4,055,636	458,264	-12.3%	Shares	Defined	2025-11-14
2025-06-30	$3,014,178	522,388	+234.7%	Shares	Defined	2025-08-14
2025-03-31	$1,030,022	156,064	+734.3%	Shares	Defined	2025-05-15
2024-12-31	$162,920	18,705	+9.0%	Shares	Defined	2025-02-14
2020-12-31	$560,380	17,158	-30.2%	Shares	Defined	2021-02-16
2020-09-30	$753,008	24,576	+33.6%	Shares	Defined	2020-11-16
2020-06-30	$299,870	18,397	+34.2%	Shares	Defined	2020-08-14
2020-03-31	$136,414	13,710	—	Shares	Defined	2020-05-15
No filing history on record for this holder in this stock.